Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies

被引:33
|
作者
Leas, Eric C. [1 ]
Hendrickson, Erik M. [1 ,2 ]
Nobles, Alicia L. [1 ,3 ]
Todd, Rory [1 ]
Smith, Davey M. [3 ]
Dredze, Mark [4 ]
Ayers, John W. [1 ,3 ]
机构
[1] Univ Calif San Diego, Ctr Data Driven Hlth, Qualcomm Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA
[4] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA
关键词
SOLD;
D O I
10.1001/jamanetworkopen.2020.20977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Question Is the public using cannabidiol (CBD) to treat diagnosable conditions that have evidence-based therapies? Findings In this case series of 376 posts on a CBD forum on Reddit, most users reported taking CBD as a therapeutic for diagnosable conditions, including mental health, cardiological, dermatological, gastroenterological, ophthalmological, oral health, and sexual health conditions, many of which have other evidence-based treatment regimens. Meaning The findings suggest a need for interventions that address the use of CBD for unproven applications, including regulating therapeutic claims about CBD and redirecting patients to proven therapies in lieu of CBD. Importance Use of cannabidiol (CBD) has markedly increased in the past 5 years, concurrent with marketing claims that over-the-counter CBD can be used to treat almost any health condition. However, the reasons why individuals use CBD remain unclear. Objective To assess whether individuals are using CBD for diagnosable conditions that have evidence-based therapies. Design, Setting, and Participants This case series assessed claimed treatment applications reported by CBD users in public testimonials shared on the Reddit forum r/CBD. The r/CBD forum was selected because it includes a large, naturally occurring sample of 104917 registered individuals who publicly discuss their experiences using CBD. All r/CBD posts were obtained from January 1, 2014, through August 31, 2019. A random sample of posts was drawn (n = 3000) and filtered to include posts in which self-identified CBD users testified why they take CBD (n = 376). Exposures Self-reported use of CBD for medicinal purposes. Main Outcomes and Measures Cannabidiol testimonials were divided into 11 subcategories corresponding with the condition's medical subspecialty and 2 subcategories corresponding with wellness benefits. Posts were allowed to receive more than 1 label. Results Of the 376 posts labeled as testimonials, 90.0% (95% CI, 86.8%-92.8%) of testimonials claimed that CBD treated the individual's diagnosable conditions. Psychiatric conditions (eg, autism or depression) were the most frequently cited subcategory, mentioned in 63.9% (95% CI, 59.0%-69.1%) of testimonials, followed by orthopedic (26.4%; 95% CI, 21.8%-31.1%), sleep (14.6%; 95% CI, 11.3%-18.5%), and neurological (6.9%; 95% CI, 4.4%-9.6%) conditions. Testimonials also claimed that CBD treated gastroenterological conditions (3.9%; 95% CI, 1.9%-6.1%), as well as addiction, cardiological, dermatological, ophthalmological, oral health, and sexual health conditions (<2.0% each). By contrast, just 29.5% (95% CI, 24.8%-34.2%) of testimonies claimed any wellness benefit, with most citing mental wellness (eg, "quieting my mind") (29.5% [95% CI, 24.2%-34.4%]); 1.4% (95% CI, 0.3%-2.8%) claimed a physical wellness benefit (eg, "exercise performance"). Conclusions and Relevance The findings of this case series suggest a need for regulation of factors associated with CBD being used to treat diagnosable conditions, engagement of health care professionals with patients on their potential CBD use, and implementation of public health campaigns that encourage the public to seek treatment advice from health care professionals regarding evidence-based therapies. This case series assesses whether individuals are using cannabidiol (CBD) to treat diagnosable conditions with proven therapies.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] EFFECT OF SURVEY CONDITIONS ON SELF-REPORTED SUBSTANCE USE
    HOYT, GM
    CHALOUPKA, FJ
    [J]. CONTEMPORARY ECONOMIC POLICY, 1994, 12 (03): : 109 - 121
  • [2] Use of CBD (cannabidiol) Oils and CBD (Cannabidiol) Suppositories in Dysmenorrhea and Endometriosis Pain
    Pleyer, I
    Lorenz-Eberhard, G.
    Boandl, G.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E7 - E8
  • [3] SELF-REPORTED USE OF ALCOHOL
    ELVY, GA
    WELLS, JE
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1983, 96 (731) : 361 - 361
  • [4] CHARACTERIZATION OF PERINATAL CANNABIDIOL (CBD) USE
    Bhatia, Devika
    Mikulich, Susan
    Sakai, Joseph
    Hammond, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S174 - S174
  • [5] Cannabidiol (CBD): Potential Use in Otorhinolaryngology
    Jotz, Geraldo Pereira
    Ortiz, Rafael Scorsatto
    Limberger, Renata Pereira
    Camargo, Flavio Anastacio de Oliveira
    [J]. INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2024, 28 (01) : E1 - E2
  • [6] The use of cannabidiol (CBD) as an analgesic component
    Petersen, Kristian Kjaer -Staal
    Rice, Andrew S. C.
    Arendt-Nielsen, Lars
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2023, 35
  • [7] Self-reported Use of Complementary and Alternative Medicine Therapies in a Reflexology Randomized Clinical Trial
    Wyatt, Gwen
    Sikorskii, Alla
    You, Mel
    [J]. ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2013, 19 (05) : 31 - 37
  • [8] Associations of Self-Reported Periodontal Disease With Metabolic Syndrome and Number of Self-Reported Chronic Conditions
    Bensley, Lillian
    VanEenwyk, Juliet
    Ossiander, Eric M.
    [J]. PREVENTING CHRONIC DISEASE, 2011, 8 (03):
  • [9] ASSOCIATIONS OF SELF-REPORTED PERIODONTAL DISEASE WITH METABOLIC SYNDROME AND NUMBER OF SELF-REPORTED CHRONIC CONDITIONS
    Bensley, L.
    Eenwyk, J. V.
    Ossiander, E.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S116 - S116
  • [10] THE VALIDITY OF SELF-REPORTED CONDOM USE
    COHEN, DA
    DENT, C
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (11) : 1563 - 1564